NO20021604L - Leptin assay - Google Patents

Leptin assay

Info

Publication number
NO20021604L
NO20021604L NO20021604A NO20021604A NO20021604L NO 20021604 L NO20021604 L NO 20021604L NO 20021604 A NO20021604 A NO 20021604A NO 20021604 A NO20021604 A NO 20021604A NO 20021604 L NO20021604 L NO 20021604L
Authority
NO
Norway
Prior art keywords
leptin assay
leptin
assay
Prior art date
Application number
NO20021604A
Other languages
English (en)
Other versions
NO20021604D0 (no
Inventor
Menachem Rubinstein
Batya Cohen
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO20021604L publication Critical patent/NO20021604L/no
Publication of NO20021604D0 publication Critical patent/NO20021604D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
NO20021604A 1999-10-11 2002-04-04 Leptin assay NO20021604D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13231399A IL132313A0 (en) 1999-10-11 1999-10-11 Leptin assay
PCT/IL2000/000621 WO2001027319A2 (en) 1999-10-10 2000-10-05 Leptin assay based on detecting ang-2 expression

Publications (2)

Publication Number Publication Date
NO20021604L true NO20021604L (no) 2002-04-04
NO20021604D0 NO20021604D0 (no) 2002-04-04

Family

ID=11073317

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021604A NO20021604D0 (no) 1999-10-11 2002-04-04 Leptin assay

Country Status (24)

Country Link
US (1) US7247427B1 (no)
EP (1) EP1222467B1 (no)
JP (1) JP2003511057A (no)
KR (1) KR100863580B1 (no)
CN (1) CN1159585C (no)
AR (1) AR025995A1 (no)
AT (1) ATE322017T1 (no)
AU (1) AU778727B2 (no)
BR (1) BR0014626A (no)
CA (1) CA2386365A1 (no)
CY (1) CY1105025T1 (no)
DE (1) DE60027031T2 (no)
DK (1) DK1222467T3 (no)
EA (1) EA004709B1 (no)
EE (1) EE200200189A (no)
ES (1) ES2256045T3 (no)
HK (1) HK1048514B (no)
IL (2) IL132313A0 (no)
NO (1) NO20021604D0 (no)
PT (1) PT1222467E (no)
SI (1) SI1222467T1 (no)
UA (1) UA77153C2 (no)
WO (1) WO2001027319A2 (no)
ZA (1) ZA200202155B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2372364A1 (en) * 2010-03-31 2011-10-05 Medizinische Hochschule Hannover Biomarker for pulmonary hypertension
WO2012094636A2 (en) 2011-01-07 2012-07-12 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
US9795792B2 (en) 2011-02-25 2017-10-24 Medtronic, Inc. Emergency mode switching for non-pacing modes
CN102221615A (zh) * 2011-03-31 2011-10-19 广州华灿医药科技有限公司 一种基于Angiogenin检测的双抗夹心ELISA方法
BR112014016808B1 (pt) 2012-01-06 2022-01-11 Anji Pharma (Us) Llc Uso de um composto de biguanida para a fabricação de um medicamento para baixar os níveis de glicose no sangue e para o tratamento de um distúrbio do metabolismo de glicose
CN104349773A (zh) 2012-01-06 2015-02-11 埃尔舍利克斯治疗公司 用于治疗代谢性病症的组合物和方法
WO2013158928A2 (en) 2012-04-18 2013-10-24 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
AU2013290100A1 (en) 2012-07-11 2015-01-29 Elcelyx Therapeutics, Inc. Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
CN102901823A (zh) * 2012-10-26 2013-01-30 安徽安科生物工程(集团)股份有限公司 瘦素检测试剂盒
EP2941245B1 (en) 2013-01-05 2024-06-26 Anji Pharmaceuticals Inc. Delayed-release composition comprising biguanide
CN104459105B (zh) * 2014-12-05 2016-03-09 重庆中元生物技术有限公司 一种检测lp的胶乳增强免疫比浊试剂盒及其制备方法
CN115901697B (zh) * 2021-08-26 2026-03-17 苏州生物医药转化工程中心 一种检测瘦素相关蛋白或其类似物的活性的方法
CN114940717B (zh) * 2022-06-30 2024-04-26 武汉海特生物制药股份有限公司 嵌合受体、32d瘦素敏感细胞株及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2252443A1 (en) * 1996-04-22 1997-10-30 Merck & Co., Inc. Leptin assay

Also Published As

Publication number Publication date
WO2001027319A2 (en) 2001-04-19
ES2256045T3 (es) 2006-07-16
IL149021A (en) 2007-12-03
ZA200202155B (en) 2003-05-28
SI1222467T1 (sl) 2006-06-30
WO2001027319A3 (en) 2001-06-21
IL132313A0 (en) 2001-03-19
DK1222467T3 (da) 2006-08-07
KR20020048416A (ko) 2002-06-22
IL149021A0 (en) 2002-11-10
PT1222467E (pt) 2006-06-30
EP1222467A2 (en) 2002-07-17
EA004709B1 (ru) 2004-06-24
AU7814100A (en) 2001-04-23
EP1222467B1 (en) 2006-03-29
CA2386365A1 (en) 2001-04-19
EA200200435A1 (ru) 2002-10-31
JP2003511057A (ja) 2003-03-25
CY1105025T1 (el) 2010-03-03
HK1048514B (zh) 2004-12-31
US7247427B1 (en) 2007-07-24
CN1378648A (zh) 2002-11-06
EE200200189A (et) 2003-06-16
KR100863580B1 (ko) 2008-10-15
UA77153C2 (en) 2006-11-15
AU778727B2 (en) 2004-12-16
ATE322017T1 (de) 2006-04-15
NO20021604D0 (no) 2002-04-04
DE60027031T2 (de) 2006-08-24
CN1159585C (zh) 2004-07-28
BR0014626A (pt) 2002-06-11
DE60027031D1 (de) 2006-05-18
HK1048514A1 (en) 2003-04-04
AR025995A1 (es) 2002-12-26

Similar Documents

Publication Publication Date Title
DE50010505D1 (de) Gurtaufrollersystem
DE122007000064I2 (de) Erythropoietinkonjugate
DE10084676T1 (de) Einmallanzettvorrichtung
DE50002834D1 (de) Handstempel
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
NO20021394D0 (no) Quetiapingranuler
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
DE50009570D1 (de) Wechselcorrugator
DE50015451D1 (de) Spülwannensystem
DE60012576D1 (de) Spreizfaktorbestimmung
DE50007953D1 (de) Beleuchtungsanordung
DE50008613D1 (de) Sicherungsring
NO20021604D0 (no) Leptin assay
DE50012482D1 (de) Tibiamarknagel
DE50000805D1 (de) Aufsitzspanner
DE50006899D1 (de) Antistatikum
DE10085008T1 (de) Oberflächenbehandlungsdüse
DE50006013D1 (de) Anschlagpuffer
DE50003660D1 (de) Diacylhydrazinderivate
DE19983890T1 (de) Ventiltaktgebungsjustiereinrichtung
DE50001640D1 (de) Nahfeldoptische untersuchungsvorrichtung
DE50008429D1 (de) Kraftstofffraktioniereinrichtung
DE50006759D1 (de) Piperidinalkohole
NO20020690L (no) Injeksonsanordning
ATE440824T1 (de) Nitro-sulfobenzamide

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application